Indian restaurants are adapting to a growing consumer base using weight-loss medications like Ozempic and Mounjaro by introducing "Size O" ...

India's economy in 2025 faced challenges from US tariffs and foreign investor exits. Despite these, domestic demand and reforms fueled stro...

The Delhi High Court has taken a firm stand by rejecting Novo Nordisk's plea to pause a prior ruling. This decision empowers Dr Reddy's Lab...

The Delhi High Court declined to stay a single-judge order allowing Dr. Reddy's to export its semaglutide, observing Novo Nordisk's appeal ...

The Delhi High Court has allowed Sun Pharma to manufacture and export its version of semaglutide, the diabetes and anti-obesity drug made b...

The Delhi High Court has permitted Dr Reddy's Laboratories to produce and export its version of the diabetes and anti-obesity drug semaglut...

The lawyers representing Natco Pharma informed the court that over the past few months it had approached Novo Nordisk to communicate on its...

New diabetes and obesity drugs, like Mounjaro and Ozempic, are changing people's relationships with food. While these drugs help control di...

The rising popularity of weight-loss drugs like Mounjaro and Wegovy is poised to create new opportunities for various sectors beyond pharma...

India is emerging as a key player in the global weight management industry, driven by a rising obesity crisis and the impending patent expi...

The Delhi High Court has granted an interim injunction against Zydus Lifesciences, an Ahmedabad-based drug maker, following a patent infrin...

Doctors say patients come with specific queries regarding weight-loss drugs, which have become both the first preference and the last resor...